Literature DB >> 31404298

Ursolic acid suppresses the biological function of osteosarcoma cells.

Yi Pei1, Yueyan Zhang2, Ke Zheng1, Guanning Shang1, Yuming Wang1, Wei Wang1, Enduo Qiu1, Xiaojing Zhang1.   

Abstract

Osteosarcoma is a highly malignant tumour that occurs in adolescents. Upregulation or the constitutive activation of epidermal growth factor receptor (EGFR) is a hallmark of osteosarcoma. To investigate the effect of ursolic acid on the biological function of osteosarcoma, MTT assay was used to detect the effect of ursolic acid on the proliferation of HOS and MG63 cells, while flow cytometry was used to analyse the effect on the cell cycle and apoptosis. Transwell and Matrigel assays were used to detect the effect of ursolic acid on cell migration and invasion, respectively. Western blot analysis and reverse transcription-quantitative polymerase chain reaction were used to detect the effects of different concentrations of ursolic acid on EGFR signaling pathway-related proteins, cell cycle, apoptosis and cell migration-related proteins. After overexpression or silencing of EGFR, the effects of ursolic acid on EGFR pathway and cell biological function were subsequently detected, using the same methods. The present study identified that ursolic acid had inhibitory effects on the growth and metastatic ability of osteosarcoma cells by suppressing EGFR.

Entities:  

Keywords:  epidermal growth factor receptor; osteosarcoma; signaling pathway; ursolic acid

Year:  2019        PMID: 31404298      PMCID: PMC6676741          DOI: 10.3892/ol.2019.10561

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

1.  Involvement of MMP-2 in adriamycin resistance dependent on ERK1/2 signal pathway in human osteosarcoma MG-63 cells.

Authors:  Ye Ren; Fengjing Guo; Anmin Chen; Rui Deng; Jiang Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

2.  Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.

Authors:  Yih-Shou Hsieh; Shu-Chen Chu; Shun-Fa Yang; Pei-Ni Chen; Yu-Chuan Liu; Ko-Hsiu Lu
Journal:  Carcinogenesis       Date:  2006-11-20       Impact factor: 4.944

3.  15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.

Authors:  Kerstin Kitz; Werner Windischhofer; Hans-Jörg Leis; Evelyn Huber; Manfred Kollroser; Ernst Malle
Journal:  Free Radic Biol Med       Date:  2011-01-12       Impact factor: 7.376

Review 4.  EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Authors:  Cristina Zahonero; Pilar Sánchez-Gómez
Journal:  Cell Mol Life Sci       Date:  2014-03-27       Impact factor: 9.261

5.  Met interacts with EGFR and Ron in canine osteosarcoma.

Authors:  J K McCleese; M D Bear; S K Kulp; C Mazcko; C Khanna; C A London
Journal:  Vet Comp Oncol       Date:  2011-12-08       Impact factor: 2.613

6.  Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells.

Authors:  Yumiko Achiwa; Kiyosi Hasegawa; Takasi Komiya; Yasuhiro Udagawa
Journal:  Oncol Rep       Date:  2005-01       Impact factor: 3.906

7.  Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.

Authors:  Jens H W Pahl; S Eriaty N Ruslan; Emilie P Buddingh; Susy J Santos; Karoly Szuhai; Massimo Serra; Hans Gelderblom; Pancras C W Hogendoorn; R Maarten Egeler; Marco W Schilham; Arjan C Lankester
Journal:  Clin Cancer Res       Date:  2011-11-16       Impact factor: 12.531

8.  The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models.

Authors:  Suk-Yun Kang; Seo-Yeon Yoon; Dae-Hyun Roh; Mi-Jeong Jeon; Hyoung-Sig Seo; Dong-Kyu Uh; Young-Bae Kwon; Hyun-Woo Kim; Ho-Jae Han; Hye-Jung Lee; Jang-Hern Lee
Journal:  J Pharm Pharmacol       Date:  2008-10       Impact factor: 3.765

9.  Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.

Authors:  Serena S Freeman; Steven W Allen; Ramapriya Ganti; Jianrong Wu; Jing Ma; Xiaoping Su; Geoff Neale; Jeffrey S Dome; Najat C Daw; Joseph D Khoury
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

Review 10.  EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.

Authors:  Hui-Wen Lo
Journal:  Curr Mol Pharmacol       Date:  2010-01       Impact factor: 3.339

View more
  2 in total

1.  The Synergistic Reducing Drug Resistance Effect of Cisplatin and Ursolic Acid on Osteosarcoma through a Multistep Mechanism Involving Ferritinophagy.

Authors:  Zhen Tang; Hui Dong; Tian Li; Ning Wang; Xinghui Wei; Hao Wu; Yichao Liu; Wei Wang; Zheng Guo; Xin Xiao
Journal:  Oxid Med Cell Longev       Date:  2021-12-21       Impact factor: 6.543

2.  Ursolic acid inhibits the invasiveness of A498 cells via NLRP3 inflammasome activation.

Authors:  Yuan-Min Chen; Bi-Xia Tang; Wei-Yong Chen; Ming-Sheng Zhao
Journal:  Oncol Lett       Date:  2020-08-28       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.